Research programme: sirolimus-eluting coronary balloon - Micell TechnologiesAlternative Names: Drug-eluting coronary balloon - Micell Technologies
Latest Information Update: 18 Jul 2014
At a glance
- Originator Micell Technologies
- Class Lactones; Macrolides; Polyenes; Pyridines
- Mechanism of Action MTOR protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Vascular disorders
Most Recent Events
- 18 Jul 2014 Early research is ongoing in USA
- 12 Jan 2009 Early research in Vascular disorders in USA (Intracoronary)